95% of healthcare AI projects never reach production.* Not because the technology doesn't work—because vendors only solve part of the problem.
Our 4-phase, 10-step methodology—Discover, Experiment, Engineer, Optimize—delivers the complete value chain from messy healthcare data to measurable outcomes. That’s why we have a One team, concept to scale while the industry average is 5%.
*MIT Project NANDA, "The GenAI Divide: State of AI in Business 2025"
Collaborative healthcare technology development
Most vendors stop at steps 1–4 (data + algorithms). They ignore steps 5–10—the 70% that determines actual success.
Write code, throw it over the wall. No healthcare expertise. No implementation support. No accountability for results.
Sell tools, wish you luck. Built for demos, not your EHR. No integration, no adoption support, no workflow fit.
Advise forever, never transfer knowledge. Strategy without delivery. Beautiful decks that never become working software.
Build cheap, miss compliance. Timezone gaps, quality issues, HIPAA concerns. No on-site discovery possible.
The industry failure rate tells the story:
95% of enterprise AI solutions never reach production. Over 2/3 of AI transformations fall short of expectations. The problem isn't the technology—it's incomplete solutions.
Industry production rate
“Despite $30–40 billion in enterprise AI investment, 95% of organizations are getting zero return.”
Why pilots stall: “Most fail due to brittle workflows, lack of contextual learning, and misalignment with day-to-day operations.”
What a CIO told researchers: “We've seen dozens of demos this year. Maybe one or two are genuinely useful. The rest are wrappers or science projects.”
Partners outperform internal builds 2:1. “Pilots built via strategic partnerships were 2x as likely to reach full deployment as those built internally. Employee usage rates were nearly double for externally built tools.”
What enterprises want: “Deep understanding of our workflow. Minimal disruption to current tools. The ability to improve over time.”
We’ve been building with AI for over 10 years. We’re exactly the kind of partner MIT’s research says you need—one team, concept to scale.
Start a conversation →Source: "The GenAI Divide: State of AI in Business 2025", MIT NANDA — Challapally, Pease, Raskar, Chari. Based on 300+ public AI initiatives, 52 org interviews, 153 senior leader surveys.
Our methodology maps directly to the healthcare AI value chain. Each step is tailored for healthcare. Each addresses a common failure pattern. Together, they explain our One team, concept to scale.
Clean, structure, prepare healthcare data
Co-design with care teams, map opportunities
Define what we’re testing and clinical success criteria
Working software, tested on your data
Sprints with continuous clinical feedback
EHR, claims, pharmacy, lab connectivity
Training and adoption support
Phased rollout with monitoring
Measure outcomes, prove ROI
Ongoing optimization or clean handoff. 100% IP yours.
✓ Result: One team, concept to scale. $20M+ verified ROI. Systems that get smarter over time.
Scroll through the complete methodology below, organized by our four phases.
Clean, structure, and prepare your messy healthcare data. Most projects assume data is ready—it never is. We start with data reality, not assumptions.
What this means in healthcare:
PHI handling with HIPAA compliance from day one. Multi-source integration: EHR + claims + labs + medications. Data quality assessment across facilities. Real-time pipelines for clinical decision support. Audit trails and access controls built in.
Common failure pattern:
Projects launch assuming data is clean and accessible. Discovery: data lives in 5 systems, quality varies by facility, no one owns data governance. Project stalls at month 3.
Build WITH your teams, not imposed on them. Requirements defined in conference rooms fail. Real understanding comes from being there.
What this means in healthcare:
40+ hours shadowing MDS coordinators, clinicians, staff. Workflow observation before requirements. Clinician feedback loops throughout development. Staff own the solution from day one.
Common failure pattern:
IT defines requirements. Vendor builds to spec. Go-live: "This doesn't match how we actually work." Expensive change orders. Staff resentment. Tool becomes shelfware.
Define what we’re testing and how we’ll know it works. Every recommendation must be audit-defensible and clinically meaningful.
What this means in healthcare:
Peer-reviewed methodologies (CMS models). 90%+ diagnosis accuracy, validated. Every recommendation linked to source documentation. Audit-defensible AI for compliance reviews.
Common failure pattern:
AI vendor ships impressive demo. Clinicians ask "why did it recommend this?" No answer. Trust evaporates. Tool sits unused. Subscription renewed but ROI = zero.
Working software, tested on your data. You can’t rip and replace your EHR. We build around what you have and validate on real clinical workflows.
What this means in healthcare:
PointClickCare, Epic, Gehrimed, Elation—proven integrations. Bidirectional data flows (not just read-only). Workflow-embedded (no separate login, no duplicate entry). Real-time triggers for clinical decision points.
Common failure pattern:
Vendor promises "easy integration." Reality: 6-month integration project, requires separate login, staff enters data twice. Adoption collapses under workflow friction.
Sprints with continuous clinical feedback. We don’t disappear into a black box for months. Your care teams see working software every two weeks.
What this means in healthcare:
2-week sprint cycles with clinician demos. Clinician feedback incorporated every iteration. Working software, not slide decks. Compliance review checkpoints built into every sprint. CI/CD pipelines with automated HIPAA guardrails.
Common failure pattern:
Vendor disappears for 6 months. Delivers “Phase 1” that doesn’t match clinical workflows. Expensive rework. Timeline doubles. Budget exhausted before production.
Wrap around existing systems seamlessly. You can’t rip and replace your EHR. We integrate with what you have.
What this means in healthcare:
PointClickCare, Epic, Gehrimed, Elation—proven integrations. Bidirectional data flows (not just read-only). Workflow-embedded (no separate login, no duplicate entry). Real-time triggers for clinical decision points.
Common failure pattern:
Vendor promises “easy integration.” Reality: 6-month integration project, requires separate login, staff enters data twice. Adoption collapses under workflow friction.
Drive adoption through your organization. Technology adoption is a people problem, not a technical problem. This is the 70% most vendors ignore.
What this means in healthcare:
Training programs for clinicians and staff. Super-user identification and empowerment. Resistance management (clinicians are skeptical of AI). Communication strategy for organization-wide adoption.
Common failure pattern:
“If we build it, they will use it”—never true in healthcare. No training budget. No change champions. Clinicians route around the tool. Usage: 15%. ROI: nonexistent.
Phased rollout with monitoring. We don’t disappear at deployment. The hardest part comes after the code is written.
What this means in healthcare:
Phased rollout: pilot facility→multi-facility→enterprise. Go-live support with on-site presence. Issue triage and rapid resolution. Performance monitoring dashboards. 24/7 support for clinical operations.
Common failure pattern:
“Deploy and disappear”—vendor hands off, support ticket queue. Problems emerge. No one on-site. Issues escalate. Leadership loses confidence. Project labeled “failed.”
Contractually tied to measurable outcomes. Your success = our success. Not promises—accountability.
What this means in healthcare:
KPIs tied to reimbursement outcomes (PDPM, RAF, denial rates). Financial analyst validated, not vendor estimates. Transparent reporting dashboards. Course correction protocols if targets aren’t met.
Common failure pattern:
Vendor promises “20% efficiency improvement.” No baseline. No measurement. Year-end: “We think it’s working?” No data. No accountability. Next year: same vendor, same promises.
Ongoing optimization or clean handoff. No vendor lock-in. 100% IP is yours. You control the long-term relationship.
What this means in healthcare:
Your IP, your choice. Knowledge transfer protocols. Documentation for internal maintenance. Option: ongoing partnership for continuous optimization. Option: full handoff to internal team.
Common failure pattern:
Vendor lock-in creates dependency. Costs escalate annually. Can’t switch—too much institutional knowledge trapped with vendor. Hostage to renewal negotiations.
Our proof:
$10M PDPM recovered. $2M quality incentives. $10M+ RAF improvements. Financial analyst calculated, not marketing estimates.
PDPM Revenue
Quality Incentives
10-step value chain: 40+ hours shadowing MDS coordinators→co-designed solution→production across multiple states→contractual KPI accountability.
Improvements
Diagnosis Accuracy
10-step value chain: Multi-source data integration→peer-reviewed CMS models→explainable AI→7-state deployment→measurable outcomes.
Patients Served
Platform Scale
10-step value chain: 90-day MVP→Salesforce replacement→18-month transformation→7-state production platform. We operate this daily.
"Digital Scientists provided immense value to our plan administrators, providers, and patients. The team was able to come in and understand our core needs, while remaining product agnostic. They helped identify the technical debt and pitfalls, and to get us to a point of stabilization and growth."
Robert Hager
CEO, CommuniCare Advantage
18-month implementation cycles mean decisions made in Q1 2026 determine who's operational by mid-2027. Organizations that wait until Q3 2026 won't reach production until 2028-12+ months behind early movers.
AI that learns from your data creates compounding advantages. Your workflows shape your system. Your documentation patterns train your models. Early movers build switching costs that late movers can't overcome.
The organizations winning in 2026 will have systems that get smarter every month-trained on their data, embedded in their operations. Those who wait will spend years catching up, if they can catch up at all.
Q1 2026 Start:
Q3 2026 Start:
30-minute discovery call. No pitch. Just honest assessment of what's possible-and whether we're the right partner.
Schedule AI Opportunity Assessment